CBIO stock

Crescent Biopharma, Inc. (CBIO) valuation · rev $10.8M

Crescent Biopharma, Inc. (CBIO) rev $10.8M.

Cached valuation scalars
MetricValue
Market cap$491.3M
Revenue$10.8M
P/S45.3
P/B2.8
These valuation metrics as JSON? API free 100/day

CBIO valuation FAQ

What is CBIO's market cap?

Crescent Biopharma, Inc. (CBIO) market cap is $491.3M on the latest cached fundamentals snapshot.

What is CBIO's latest revenue?

Latest cached Crescent Biopharma, Inc. (CBIO) revenue was $10.8M. Statements: https://lician.com/financials/cbio

What is CBIO's price-to-sales ratio?

Crescent Biopharma, Inc. (CBIO) price-to-sales (P/S) is 45.3, cached market cap $491.3M divided by revenue $10.8M.

What is CBIO's price-to-book ratio?

Crescent Biopharma, Inc. (CBIO) price-to-book (P/B) is 2.8 on the latest cached fundamentals snapshot.

How many CBIO valuation scalars are listed on this page?

This page lists 4 cached valuation scalars for Crescent Biopharma, Inc. (CBIO): Market cap, Revenue, P/S, and P/B.

Where is CBIO valuation listed?

Cached valuation multiples for Crescent Biopharma, Inc. (CBIO) are listed at https://lician.com/valuation/cbio.

Not investment advice. Cached rows, not a live tape.